Cardinal Health Inc. 2022-05-25 Health serious FDA
Health · FDA · Recall #FDA-D-0884-2022
Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx… Recall
Issued May 25, 2022 · Cardinal Health Inc.
In May 2022, Cardinal Health Inc. recalled the Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
What you should do
- 1 Stop using Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Cardinal Health Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Cardinal Health Inc.
- Category
- Health
- Recall date
- May 25, 2022
- Units affected
- Not reported
- Sold at
- NM only
- Recall number
- FDA-D-0884-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Cardinal Health Inc. has 8 recalls in our database, including 4 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.